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PENYELIDIKAN AWAL KESAN STIMULASI 
MAGNETIK TRANSKRANIAL BERULANG (rTMS) TERHADAP 
BIOMARKER MUSCULOSKELETAL PADA PESAKIT ANGIN AHMAR 




 Penyebab utama kecacatan jangka panjang disebabkan oleh angin ahmar ialah 
fungsi motor yang terjejas. “Neuroplasticity” ialah suatu perubahan yang berlaku di 
bahagian korteks dan merupakan proses penting untuk pemulihan fungsi motor setelah 
serangan angin ahmar. Rangsangan magnetik transcranial berulang (rTMS) merupakan 
sejenis rangsangan otak tidak invasif, yang diguna untuk menggalakkan proses 
“neuroplasticity” dengan mengubah rangsangan di bahagian kortikal otak. Kami menguji 
kesan rTMS apabila rangsangan magnetik diberi ke korteks motor utama (M1) di pada 
bahagian otak yang tercedera. Kajian terdahulu telah melaporkan peningkatan tahap serum 
Creatine Kinase (CK) dan Troponin T di kalangan individu yang mengalami angin ahmar. 
Enzim serum ini digunakan secara meluas sebagai biomarker untuk mengenalpasti fungsi 
otot. Tujuan kajian ini adalah untuk menilai perubahan dalam tahap CK dan Troponin T 
sebagai tindak balas kepada 10 Hz rTMS pada individu yang mengalami serangan angin 
ahmar (jenis iskemik dan hemoragik).  
 Seramai lapan pesakit angin ahmar yang memenuhi kriteria inklusi dan 
pengecualian telah dibenarkan untuk menyertai kajian ini. Mereka menjalani 10 sesi 
xvii 
 
protokol “fascilitatory” rTMS pada bahagian otak serangan angin ahmar selama dua 
minggu. Sampel darah pesakit telah diperoleh sebelum dan selepas intervensi rTMS untuk 
menganalisis tahap serum CK dan Troponin T. Analisis statistik menunjukkan bahawa 
tiada perubahan signifikan dalam nilai median CK dan Troponin T sebelum dan selepas 
rTMS. Analisis deskriptif menunjukkan bahawa nilai median CK dan Troponin T sebelum 
sesi rTMS bermula adalah lebih tinggi daripada nilai selepas rTMS dalam sampel ini. 
Tambahan lagi, pesakit strok dalam kategori umur yang lebih tua didapati mempunyai 
tahap CK dan Troponin T yang lebih tinggi berbanding pesakit yang lebih muda. 
Konklusinya, terdapat perbezaan dalam aktiviti CK dan Troponin T dalam setiap pesakit 
angin ahmar, dan ia disebabkan oleh beberapa pembolehubah dan saiz sampel yang agak 
kecil. Oleh itu, kajian masa hadapan adalah dicadangkan untuk menganalisis kesan faktor-
faktor seperti status aktiviti fizikal, sejarah perubatan pesakit dan jenis ubat-ubatan ke atas 
tahap serum biomarker tersebut, untuk digunakan sebagai penilai integriti sel-sel otot 










EXPLORATORY RESEARCH ON THE EFFECTS OF  
REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (rTMS) 
ON MUSCULOSKELETAL BIOMARKERS ON STROKE PATIENTS 




 The leading cause of long-term disability caused by stroke is motor impairment. 
Neuroplasticity-induced cortical reorganization is a crucial process mediating motor 
recovery following stroke. Repetitive transcranial magnetic stimulation (rTMS) is a form of 
non-invasive brain stimulation approach that promotes neuroplasticity by modulating 
cortical excitability. We tested the effects of rTMS, when delivered over the ipsilesional 
hemisphere at the site of primary motor cortex (M1). Previous studies have reported 
elevated levels of serum Creatine Kinase (CK) and Troponin T among individuals with 
stroke. These serum enzymes are widely used as biomarkers for functional status of skeletal 
muscles. The aim of the present study is to assess the changes in the CK and Troponin T 
levels in response to 10 Hz rTMS in individuals with ischemic and hemorrhagic stroke.  
 Eight stroke patients were screened according to inclusion and exclusion criteria. 
Subsequently, they were subjected to 10 sessions of fascilitatory protocol of rTMS on the 
ipsilesional hemisphere for a period of two weeks. The blood samples of the patients were 
obtained pre- and post-intervention in order to analyze the levels of CK and Troponin T. 
Statistical analysis revealed that there is no statistically significant difference in the median 
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values of CK and Troponin T pre- and post-rTMS. Descriptive analysis indicated that the 
median values of CK and Troponin T at the baseline are higher than post-rTMS in this 
sample. In addition, stroke patients in the older age group were found to have higher levels 
of CK and Troponin T as compared to the younger patients. The considerable 
interindividual variability in CK and Troponin T activities among stroke patients can be 
ascribed to several confounding variables and relatively small sample size. Therefore, it can 
be suggested that future studies may include factors such as physical activity status, 
medical history of patients and types of medications in the analysis in order to assess the 
serum levels of aforementioned biomarkers, as a reliable indicator of muscle cells integrity 










1.1 Introduction  
 
 Stroke is a neurological condition that occurs in the central nervous system and 
causes wide range of cognitive and physical deficits. This neurological disorder is also 
known as cerebrovascular accident among medical community. It occurs when the blood 
supply to a region of the brain is obstructed, potentially causing the death of neural tissues 
due to insufficient supply of glucose and oxygen. Stroke can be classified into two broad 
categories, namely ischemic and hemorrhagic stroke. Most of the strokes happen due to 
occlusion of the blood supply by a clot, known as ischemic stroke. Hemorrhagic stroke, on 
the other hand, occurs when a blood vessel within the brain ruptures, causing bleeding in 
the brain (Benjamin et al., 2018).  
 
 The Global Burden of Disease (GBD) 2013 study showed that stroke is a major 
cause of death and disability in many countries. In 2013 alone, it was reported that there 
were approximately 6.5 million deaths due to stroke, 25.7 million stroke survivors, 113 
million disability-adjusted-life years (DALYs) lost as well as 10.3 million new cases of 
stroke worldwide (Feigin et al., 2015). The 2018 statistics in Malaysia has indicated 
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cerebrovascular accident as the third leading cause of deaths in the country, preceded by 
ischemic heart diseases and pneumonia (Mahidin, 2018). 
 
 Approximately 90% of the causes of stroke are due modifiable factors, and thus, 
most strokes could be precluded by controlling these factors, which are predominantly 
metabolic and behavioral in nature. The six most crucial causes are hypertension, diabetes 
mellitus, hypercholesterolemia, obesity, smoking and insufficient physical activity (Hsieh 
& Chiou, 2014). High blood pressure is accounted as the most common risk factor affecting 
populations worldwide, followed by diabetes mellitus and smoking behavior. A review on 
stroke epidemiology among Asian countries reported that Malaysia has a high prevalence 
of physical inactivity (Venketasubramanian, Yoon, Pandian, & Navarro, 2017). Moreover, 
some factors that are uncontrollable also increase the risk of stroke, such as age and gender. 
 
 One of the most commonly altered functions of the brain following stroke is the 
motor ability. An impaired motor function occurs as a result of the damage to a brain region 
associated with motor control, which is comprised of both cortical and subcortical 
structures of the brain. Occlusion of cerebral blood flow in brain regions that are 
responsible for the generation and control of voluntary movement, such as primary motor 
cortex (M1), premotor area, parietal cortex, cerebellum and basal ganglia, may result in 
motor deficits. M1 is a primary source of descending neural projections from the cerebral 
cortex to the motor neurons in the spinal cord and the cranial nerve nuclei. M1 is located in 
the precentral gyrus (Brodmann’s area 4) (Figure 1.1). One of the crucial characteristics of 
M1 is that the neurons in this cerebral region can readily be stimulated to produce motor 
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Figure 1.1: Lateral (A) and medial (B) views of the primary motor cortex (M1) and 
premotor cortex.  
  
 Treatment of cerebrovascular accident can be classified into two major categories, 
which are neuropharmacological and neurorehabilitation approaches. Pharmacological 
interventions often targeted at reducing the amount of brain injury due to ischemia, whereas 
rehabilitative strategies are implemented to involve physical, occupational and speech 
therapy that rely on neuroplasticity to promote recovery of motor functions. Any 
therapeutic modality used for neurological rehabilitation is based on assumptions about the 
functioning of central nervous system. Novel therapeutic strategies for stroke rehabilitation 
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have started to surface in the last few years. Some of the main reasons driving these novel 
techniques are attributable to enhanced understanding of motor control and motor learning.  
 
 Repetitve transcranial magnetic stimulation (rTMS) is a non-invasive brain 
stimulation approach that has the potential to modulate neuroplasticity in order to elicit 
motor learning, following stroke (F. C. Hummel & Cohen, 2005). The interhemispheric 
imbalance model suggests that disinhibition of contralesional motor regions correlated with 
increased inhibition of ipsilesional motor regions (Duque et al., 2005). Due to these 
underpinnings, the goals of rTMS protocols can be either to enhance the cortical 
excitability in ipsilesional cortical regions using fascilitatory protocol of rTMS or to 
depress the cortical excitability in contralesional cortical regions using inhibitory protocol 
of rTMS (Yozbatiran et al., 2009). 
 
 Stroke results in long-term dysfunctions due to complex pathomechanisms, and one 
of them is neuroinflammation (R. Liu et al., 2017). Enormous research have been directed 
to identify potential neuronal anti-inflammation agents in controlling the effects of cerebral 
ischemia to the central nervous system (CNS). However, the impact of neuroinflammation 
on the skeletal muscle and peripheral nerve is still poorly understood.  
 
 Skeletal muscle tissue in stroke patients may be disrupted following the over usage 
or the underusage of skeletal muscles. In stroke patients, hemiparesis leads to underusage 
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of skeletal muscles in the affected limbs. This condition is further aggravated by 
disruptions in carbohydrate metabolism that leads to hypermetabolic state, resulting in 
decreased ATP availability and insufficiency of Na-K ATPase. This will lead to increased 
membrane permeability in skeletal muscle and thus indirectly cause muscle damage. This 
cellular event can be indicated by measuring the levels of serum enzymes, namely Creatine 
Kinase (CK) and Troponin T.   
 
 Previous studies have only focused on biomarkers of restorative therapies in CNS 
following stroke, including several neuroimaging indicators (Burke & Cramer, 2013). In 
contrast, current research evaluates the effects of rTMS on motor recovery, by measuring 
serum musculoskeletal biomarkers of stroke patients before and after intervention. These 
sera skeletal muscle enzymes indicate the functional status of skeletal muscles. As 
permeability of skeletal muscle membrane is disrupted in stroke, the muscle damage can be 
indirectly assessed by these relatively cheap, readily available biomarkers. 
 
 It has been stipulated that neuroplasticity induced by rTMS intervention may 
improve motor performance among patients, which in turn enhances the integrity of 
skeletal muscle cells and reduces the levels of these biomarkers. Therefore, this study 
attempts to examine the changes in levels of creatine kinase (CK) and Troponin T pre- and 
post-rTMS treatment. If the findings obtained in this study indicate changes on the skeletal 
muscle level, a neurorehabilitative guideline can be established in hospital USM to enhance 
motor recovery among stroke patients. 
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1.2 Problem Statement 
 
 Although constraint-induced movement therapy (CIMT) is notable in improving 
motor recovery to a certain extent among stroke patients, a full recovery is rarely achieved 
and further studies are required to elucidate its molecular mechanisms (Corbett, Sirtori, 
Castellini, Moja, & Gatti, 2015). The major limitation of traditional methods of 
neurorehabilitation, which are based on direct stimulation of muscles and peripheral nerves 
in order to indirectly influence the central nervous system (CNS), is that they have a 
moderate effect on neuroplasticity (Mohammadi, 2016). The review by Cochrane has 
selected 15 studies with 455 stroke patients and could not conclude that there was a strong 
evidence of efficacy of transcranial direct current stimulation (tDCS) (Elsner, Kugler, Pohl, 
& Mehrholz, 2013).  
 
 As an alternative, it has been postulated that direct stimulation of the CNS by 
changing the electromagnetic field may contribute further alterations in the intracortical 
connections which are related to motor recovery, with the use of rTMS. Repetitive 
transcranial magnetic stimulation (rTMS) is a neuromodulatory tool that is entirely non-
invasive, utilized to induce neuroplasticity in order to produce therapeutic effects on motor 
impairment among stroke patients. Since the protocols of rTMS varied, it requires 
extensive pre-clinical and clinical trials to determine which specific parameter is best used 
as a neurorehabilitative approach.  
 
 The aim of this research is to assess the effects of 10 Hz rTMS over ipsilesional 
primary motor cortex (M1) that is conducted for 10 consecutive days on musculoskeletal 
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biomarkers, namely creatine kinase (CK) and troponin T. The outcome measure is the 
levels of musculoskeletal serum biomarkers, namely Creatine Kinase and Troponin T. The 
underusage of motor movement among stroke patients causes the levels of these 
biomarkers to be increased in the serum plasma due to skeletal muscle injury. Therefore, 
rTMS is postulated to improve the motor abilities among stroke patients, which in turn 




 Current research is intended to examine the effects of high frequency repetitive 
Transcranial Magnetic Stimulation (rTMS) on changes in musculoskeletal biomarkers, 
which are Creatine Kinase and Troponin T. Fascilitatory protocol of rTMS involving 10 Hz 
stimulation will be applied to the injured brain hemisphere. The design of this study does 
not require pain relieving method during the treatment and hospital stay might be needed 
during the procedure. If promising results are obtained, this study will become a guide to 
our health professionals to conduct an alternative neurorehabilitative approach using non-
invasive rTMS to promote motor recovery among stroke patients. As the musculoskeletal 
biomarkers have shown notable results in stroke recovery prognosis, rTMS can be utilized 
as a nonpharmacological strategy for rehabilitation. This study can also direct future 
researchers to conduct extensive researches on therapeutic effects of non-invasive 
neurostimulation approach in promoting the well-being of stroke patients, as well as to 






1.4 Research Questions 
 
There are two questions intended to be answered by conducting this research, which are:  
1. Is there any statistical significant difference in the levels of serum creatine kinase (CK) 
between pre- and post- rTMS intervention? 
   
2. Is there any statistical significant difference in the levels of serum Troponin T between 
pre- and post- rTMS intervention?   
 
1.5 Research Objectives 
 
1.5.1 General objective 
To evaluate the changes in the levels musculoskeletal biomarkers pre- and post- 
rTMS. 
 
1.5.2 Specific objectives: 
1. To determine the changes in the levels of serum Creatine Kinase before and 
after high frequency repetitive transcranial magnetic stimulation (rTMS) is 
administered on ipsilesional hemisphere of stroke patients. 
 
2. To determine the changes in the levels of serum Troponin T before and after 
high frequency repetitive transcranial magnetic stimulation (rTMS) is 








2.1 Etiologic classification of stroke 
 
 Stroke was first described more than 2400 years ago in Hippocratic Writings using 
the term ―apoplexy‖ (Clarke, 1963), which means the paralysis of part of the body due to 
an apoplectic attack or possibly other causes. Scholars in 17
th
 century had reached out for 
new horizons, leaving the doctrines of Hippocrates and Galen behind them. During this 
time before the discovery of arterial circle by Thomas Willis, a Swiss physician, Jacob 
Wepfer, indicated that apoplexy happens due to cerebral hemorrhage (J. Pearce, 1997). He 
was the first researcher who pointed out that apoplexy could result from either the 
occlusion of one of the main arteries to the brain (ischemic stroke) or bleeding in the brain 
(hemorrhagic stroke) (Fields & Lemak, 1989).  
 
 Strokes can be categorized into two distinctive groups, which are ischemic and 
hemorrhagic stroke. These two main classifications allow further classification into 
subtypes, as represented in Figure 2.1. By applying clinical evaluations to neurological 
modalities such as Computerized Axial Tomography (CAT) scan, standard 24-hours 
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electrocardiography, echocardiography and ultrasound of intra and extracranial arteries, the 
most probable etiology is determined by the physician.  
 
 
Figure 2.1: Classification of Strokes. Source: (Adams et al., 1993) 
 
 According to the TOAST classification system, ischemic stroke can further be 
categorized into five subtypes as due to large-vessel atherosclerosis, cardioembolic origin, 
small vessel disease, other determined causes, and stroke of undetermined causes (Adams 






















Small penetrating artery 
thrombosis (lacunar stroke) 







 On the other hand, hemorrhagic stroke is less common than ischemic stroke, and 
can be subdivided into two types, which are subarachnoid and intracerebral hemorrhage. In 
intracerebral hemorrhage, bleeding occurs directly into the functional tissues of the brain 
that are comprised of neurons and glial cells (Domingues, Rossi, & Cordonnier, 2014). One 
of the causes is due to chronic intracranial hypertension, small intracerebral arteries thought 
to be leaked and cause apoplexy. Besides the affected brain region, the surrounding sites 
can also be damaged due to the pressure inflicted by the mass effect of the hematoma, 
causing more intense intracranial pressure. Another type of hemorrhagic stroke is 
subarachnoid hemorrhage, which is an uncommon stroke that is potentially life threatening 
(van Gijn & Rinkel, 2001). Similar to intracranial hemorrhage, subarachnoid hemorrhage 
also aggravates the intracranial pressure with combination of several other signs such as 
aggregation of microvascular platelets, acute vasoconstriction and loss of microvascular 
perfusion. Eventually, all these signs lead to significant reduction in cerebral blood flow 
and cause cerebral ischemia. 
 
2.2 Pathophysiology of stroke 
 
 The reduction or complete occlusion of cerebral blood flow that occurs during a 
cerebrovascular accident often leads to a complex pathophysiological response due to 
neuronal injury, as depicted in Figure 2.2 (Hossmann, 2006). A series of events including 
excitotoxicity mechanisms, inflammatory pathways, protein misfolding, the release of free 
radicals and mitochondrial response will take place and eventually lead to the death of 
neural cells. Subsequently, these cascades of cellular and molecular pathways essentially 




Figure 2.2: Pathophysiology of Stroke. Source: (Hossmann, 2006). 
 
2.2.1 Excitotoxicity mechanisms 
 
 The formation of thrombus or embolus in the cerebral artery leads to inadequate 
supply of oxygen and glucose to the brain tissues due to restricted blood flow to the brain. 
This condition is known as ischemic hypoxia. As a result, neuronal cells fail to sustain 
normal ionic gradients. Depolarization of these neurons leads to excessive glutamate 
release that eventually leads to intracellular influx of calcium, causing cell death 
mechanisms such as necrosis, autophagocytosis and apoptosis (Lipton, 1999). This course 
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of actions has been termed excitotoxicity and is largely intervened by glutamatergic 
synaptic transmission involving N-methyl-D-aspartate receptors (NMDARs), α-amino-3-
hydroxy-5-methyl-4-isoxazole-propionic acid receptors (AMPARs) and kainate receptors 
(Dirnagl, Iadecola, & Moskowitz, 1999; Moskowitz, Lo, & Iadecola, 2010). Excessive 
intracellular calcium further leads to a cascade of events, such as mitochondrial impairment 
and activation of oxidative molecules, phospholipases and proteases. These mechanisms 
account for neural cell damage or death (Szydlowska & Tymianski, 2010).  
  
2.2.2 Inflammatory pathways 
 
 Intracranial artherosclerotic disease is a common cause of stroke that is associated 
with a high risk of recurrent stroke (Banerjee & Chimowitz, 2017). Inflammatory pathways 
imply significant roles in the development of atherosclerotic plaque and initiated when 
damage to endothelium occurs (Gimbrone & García-Cardeña, 2013). 
 
 Inflammatory pathways comprised of a complex interaction of immune cells and 
inflammatory factors that lead to blood-brain barrier breakdown, reorganization of brain 
tissue post-stroke and also provide neuroprotection from the enzymes and free radicals that 
were produced due to excitotoxic environment post-stroke (Iadecola & Anrather, 2011). 
Immune cells release proinflammatory cytokines such as tumor necrosis factor- α (TNF- α) 
and interleukin-1β, as well as oxidative molecules in the neural tissues following stroke in 
order to propagate the immune response (J. Huang, Upadhyay, & Tamargo, 2006). As 
response to cytokines, inducible nitric oxide synthase (iNOS) is also released and has 
damaging effects in stroke (Moro, Cardenas, Hurtado, Leza, & Lizasoain, 2004). Earlier 
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research conducted by Arac et. al (2011) has proven that impeding acute inflammatory 
response following stroke leads to less damage and enhance neurological outcome in rodent 
models.  
 
 Inflammatory mechanism has both positive and negative consequences on the 
surviving brain tissues. The timing and levels of interaction between immune cells and 
inflammatory factors are accounted for balance of damage after stroke and the recovery 
process (Peruzzotti-Jametti et al., 2014). While immune cells produce cytokines and 
radicals that aggravate inflammatory response, they also help in eliminating post-stroke 
debris and damaged tissue in order to promote recovery of retaining tissues.  
      
2.2.3 Protein misfolding 
 
 Endoplasmic reticulum (ER) is an organelle that holds large stores of intracellular 
calcium and is responsible for protein synthesis and responds to protein misfolding (Zhang 
et al., 2015). Stroke or cerebral ischemia leads to ER stress and has effect on these cellular 
and molecular mechanisms (Roussel et al., 2013). Excitotoxic environment following 
stroke causes dysfunction of sarcoplasmic/ER calcium ATPase (SERCA) pump due to lack 
of energy, which in turn aggravates neural cell death (Szydlowska & Tymianski, 2010). 
    
2.2.4 Release of free radicals 
 
 Free radicals are oxygen-containing molecules with an uneven number of electrons 
that are released due to ischemic condition of the brain tissues. They easily react with other 
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biochemical molecules within the cellular environment. Previous research has shown that 
the influx of calcium triggers NO synthase (NOS) to secrete nitric oxide (NO) that leads to 
cell damage through the productions of peroxynitrite (ONOO-) and oxygen free radicals 
(Iadecola, 1997). The mitochondrial impairment that happens due to inadequate supply of 
blood to the brain also adds on oxidative damage (Kalogeris, Bao, & Korthuis, 2014). In 
addition to initial toxicity, free radicals also impede recovery, which makes them a crucial 
therapeutic target for stroke intervention (Miyamoto et al., 2013).  
    
2.2.5 Mitochondrial response 
 
 When the supply of oxygen to the brain is interrupted during cerebrovascular event, 
the neurons cannot break down glucose completely. As a result, the energy balance is 
disrupted and ATP synthesis is deranged. Coupled with excitotoxicity mechanism, the 
influx of calcium leads to excess accumulation in the mitochondrial matrix which in turn 
leads to the opening of mitochondrial permeability transition pore (mtPTP) and the release 
of cytochrome c (X. Liu, Kim, Yang, Jemmerson, & Wang, 1996; Murphy, Fiskum, & 
Beal, 1999). These cellular events cause mitochondria to swell and lose its integrity, paving 
ways to cell death cascades such as apoptosis (X. Liu et al., 1996). As mentioned before, 
free radicals formed my mitochondria also contributes to cell death in ischemic 







2.3 Risk Factors for Stroke 
 
 Identifying risk factors are crucial to inform stroke prevention strategies around the 
world and to reduce the global burden of stroke. There are numerous risk factors for stroke, 
comprising of both modifiable and non-modifiable risk factors. Non-modifiable factors 
include age, sex, race and genetics. The modifiable risk factors are of utmost importance, as 
health interventions should be geared towards changing lifestyle to reduce these factors 
which in turn reduces the risk of stroke. A retrospective hospital-based study in Malaysia 
has identified several controllable risk factors in stroke patients, including hypertension, 
diabetes mellitus, dyslipidemia, smoking and alcoholism (Boo et al., 2016).  
 
 Hypertension was found to be the major risk factor in stroke patients, in which, 
upon admission, the mean systolic blood pressure of the patients was 172.4 mmHg whereas 
the mean diastolic pressure was 93.8 mmHg in the aforementioned study. A recent 
prospective research conducted by Sepanlou et. al (2016) has found a significant 
association between hypertension and stroke mortality. These data indicate the profound 
role of hypertension in pathogenesis of cerebrovascular accident. High blood pressure 
causes a cascade of events, such as initiation of vasculopathy, formation of microatheroma, 
lipohyalinosis and atherosclerotic diseases, as well as disruption of blood-brain barrier 
(Hisham & Bayraktutan, 2013). Besides pharmacologic intervention, patients with 
hypertension are encouraged to involve in lifestyle changes, such as modification in diet 
and performing greater physical activity, in order to reduce the effects of hypertension 
(Chobanian et al., 2003). Intervention for hypertension, whether through medication or 
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behavioral changes, remains one of the most essential strategies in reducing the risk of 
cerebrovascular accident and its recurrence.  
 
 There is also a positive association between diabetes mellitus and incidence of 
stroke, particularly the ischemic subtype. Diabetes leads to several metabolic and 
pathologic changes that subsequently leads to stroke, including the stiffening of arteries, 
systematic inflammation, endothelial impairment and cardiac failure (R. Chen, Ovbiagele, 
& Feng, 2016; Quinn, Dawson, & Walters, 2011). With a proper dietary and weight 
management strategies, the prevalence of cardiovascular disease among diabetic patients 
can be lowered (Fox et al., 2015). This in turn reduces the risk of primary and secondary 
stroke encounter and the rate of mortality may decrease as well. 
 
 In addition to the study conducted by Boo et. al (2016), several other studies have 
pointed out that dyslipidemia is another risk factor that is associated with the occurrence of 
stroke (Sarti, Kaarisalo, & Tuomilehto, 2000; Tziomalos, Athyros, Karagiannis, & 
Mikhailidis, 2009). Dyslipidemia is defined as increased low-density lipoprotein (LDL) 
cholesterol levels, or low levels of high-density lipoprotein (HDL) cholesterol (Fodor, 
2010). Atherosclerosis is the predominant mechanism of dyslipidemia, which eventually 
leads to cerebrovascular accident (Ansell, 2000). By decreasing the lipid profiles, the 
formation of atherosclerotic plaques can be reduced which in turn reduces the risk of 
stroke. 
 
  Cigarette smoking is a significant risk factor linked with stroke. An early research 
reported that smoking contributes approximately 15% of all stroke deaths per year (Thun, 
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Apicella, & Henley, 2000). Discontinuing smoking behavior is an approach to healthier 
lifestyle and researchers have identified that risk of stroke can be significantly reduced 
nearly 2 to 4 years after smoke cessation (Burns, 2003; Fagerström, 2002; Robbins, 
Manson, Lee, Satterfield, & Hennekens, 1994; Y.-M. Song & Cho, 2008). Besides, alcohol 
consumption also has effects on cerebrovascular accidents. A meta-analysis indicated that 
light to moderate alcohol consumption was inversely linked with ischemic stroke, whereas 
heavy drinking was associated with greater risk of all types of stroke with a stronger link 
with hemorrhagic stroke. The analysis signified that heavy drinkers were about 1.6 times 
more likely to suffer from intracerebral hemorrhage and 1.8 times are likely to suffer from 
subarachnoid hemorrhage (Larsson, Wallin, Wolk, & Markus, 2016).  
 
 Several potential modifiable risk factors that preceded cerebrovascular events have 
been highlighted. Reduction of risks of hypertension, diabetes mellitus, dyslipidemia, 
smoking behavior and alcoholism gradually decreases the risks associated with stroke. A 
healthy diet, frequent physical activity, smoking cessation, alcoholism restriction, coupled 
with medical interventions for hypertension, diabetes mellitus and dyslipidemia are found 
to be efficient strategies for stroke prevention (Boehme Amelia, Esenwa, & Elkind 
Mitchell, 2017).   
 
2.4 Historic Antecedents of Transcranial Magnetic Stimulation (TMS) 
 
 Transcranial Magnetic Stimulation (TMS) is a non-invasive and painless 
armamentarium of stimulating certain cortical areas, and was developed by Dr. Antony T. 
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Barker in 1985. Following the invention, Dr. Barker won the first International Brain 
Stimulation Award for his outstanding contribution in the field of neuromodulation. 
 
 Dr. Barker initiated his research on utilizing time-differing magnetic fields to 
induce the flow of current in brain tissue in order to depolarize neurons. Prior to this 
research, the principal method used to induce neuronal depolarization is direct electrical 
stimulation that needs an attentive placement of the surface electrodes and attention on 
other aspects of the method to reduce discomfort among patients (Merton, Morton, Hill, & 
Marsden, 1982). This method was halted due several drawbacks and the high intensity of 
electrical stimulation often causes pain. On the other hand, the magnetic fields penetrate 
through the scalp and skull without being obstructed, and yields more precise results. In 
1985, Dr. Barker and his colleagues recorded the first demonstration of TMS, in which 
applying TMS to the contralateral side of the motor cortex produced twitching in a specific 
area of the hand in human participants (Barker, Jalinous, & Freeston, 1985). This pioneer 
work has indicated the profound use of TMS as a pain-free method to activate specific area 
of brain.  
 
2.4.1 Basic Principles of TMS 
 
 TMS was discovered using a fundamental idea on how magnetic fields and electric 
current interact with each other to modulate brain activity without putting patients at risk. It 
is essential to revise the connection between magnetic fields and electric current to fully 
understand the functions of TMS in treating neurological disorders. Faraday explained that 
electromagnetic induction happens when a transient current in copper coil yields a time-
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differing magnetic field which induces a new electric current in nearby conductors 
(Faraday, 1832). A year after this discovery, Russian physicist, Heinrich Friedrich Emil 
Lenz reported that the direction of the electric current induced by the magnetic field is 
opposite to the electric current flow that produces it. This phenomenon was called ―Len’s 
law‖ (Lenz, 1834). 
 
 Putting all these facts together, TMS administers a transient electric current that 
flows through a magnetic coil positioned on the scalp, producing a time-varying magnetic 
field which in turn induces electric current flow in cortical neurons, consistent with the 




Figure 2.3: The working principles of TMS. (A) Electric current flows through 
electromagnet coil. (B) Time-varying magnetic field is yielded by electric current flowing 
through the coil. (C) Electric current induced by the magnetic field is opposite to the 
electric current flow produced by coil. (D) Depolarization of neurons stimulates the 





 TMS can be administered through different kinds of coils, including those in 
circular shapes, double cone coil and ―figure-of-eight‖ coils with diameters ranging from 
40 to 90 mm (T. Wagner, Valero-Cabre, & Pascual-Leone, 2007). It has been indicated that 
the flux of the magnetic field produced by the figure-of-eight coil is more concentrated and 
more focused when compared to simple circular coils. TMS pulse in the figure-of-eight coil 
reaches a depth of 1.5 to 3 cm (Rossi, Hallett, Rossini, & Pascual-Leone, 2009; Thielscher 
& Kammer, 2004; Zangen, Roth, Voller, & Hallett, 2005). On the other hand, TMS for 
subcortical areas can be done using H-coil (Bersani et al., 2013).  
 
 Since its discovery, TMS has undergone rapid advancements in which, in recent 
years, TMS can be neuronavigated to stimulate certain parts of the cortex and associated 
with other neuroimaging techniques such as electroencephalogram (EEG), functional 
magnetic stimulation (fMRI), positron emission tomography (PET) and transcranial 
Doppler ultrasonography (Ahdab, Ayache, Brugieres, Goujon, & Lefaucheur, 2010; Bashir, 
Edwards, & Pascual-Leone, 2011; Denslow, Lomarev, George, & Bohning, 2005; Julkunen 
et al., 2009; Sack & Linden, 2003; Sparing, Buelte, Meister, Pauš, & Fink, 2008; Thut & 
Pascual-Leone, 2010).  
 
2.4.2 Methods of TMS 
 
 There are two common methods of TMS, which are single-pulse (including paired-
pulse) and repetitive TMS. Paired-pulse TMS comprised of two consecutive pulses being 
administered through the same electromagnet coil, with either a short inter-stimulus 
interval of a few milliseconds or a long inter-stimulus interval of tens to hundreds of 
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milliseconds. This neurostimulation technique is utilized to explore inhibitory or excitatory 
cortical networks depending on the intensity of stimulation and inter-stimulus interval 
being used (Kujirai et al., 1993; Tokimura, Ridding, Tokimura, Amassian, & Rothwell, 
1996; Valls-Solé, Pascual-Leone, Wassermann, & Hallett, 1992). These two pulses can also 
be applied over each hemisphere at the same area of the motor cortex in order to examine 
inter-hemispheric inhibition (Ferbert et al., 1992). 
 
 On the other hand, repetitive TMS (rTMS) is a neuromodulation technique that 
modulates cortical activity beyond the period of stimulation, and acts as a therapeutic tool 
for the treatment of neurological and psychiatric disorders. Repetitive TMS protocols 
include simple techniques such as low-frequency and high-frequency stimulations, as well 
as new modulatory approaches that include theta burst stimulation and paired associative 
stimulation. Each of this protocol has its own procedures and the outcomes differ from each 
other, depending on the frequency of stimulation and the duration of stimulation period 
(Simonetta-Moreau, 2014).  
 
 In studies that utilize low-frequency rTMS protocol, the stimulation frequency is 
usually set at 1 Hz, and scrutinized to have inhibitory effect. However, at low frequencies 
(lower than motor threshold), 1 Hz stimulation often fails to exhibit considerable effects on 
corticomotor excitability. In contrary, high frequency rTMS (5-25 Hz) enhances 
corticomotor excitability, and has received attention because it is an essential intervention 
for the recovery of upper-limb motor nerve function among stroke patients (Higgins, Koski, 
& Xie, 2013b; Sasaki, Mizutani, Kakuda, & Abo, 2013). Due to promising outcomes in 
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previous research, current research aims to demonstrate the effectiveness of 10 Hz rTMS 
protocol by examining the changes in musculoskeletal biomarkers among stroke patients.  
 
 The new rTMS methods include theta burst stimulation (TBS) and paired 
associative stimulation (PAS). Similar to simple rTMS methods, TBS has two different 
patterns of stimulation that increases and depresses the corticomotor excitability. An 
intermittent TBS (iTBS) pattern is applied for 2 s and then repeated every 10 s, results in 
enhancement of corticomotor excitability (V Di Lazzaro et al., 2010; Y.-Z. Huang, 
Edwards, Rounis, Bhatia, & Rothwell, 2005; Simonetta-Moreau, 2014). On the other hand, 
continuous TBS (cTBS) is a form of rTMS that depresses corticomotor excitability when it 
is delivered for 40 s without any interval. Researchers assume that TBS generates both 
fascilitatory and inhibitory effects, with facilitation occurs faster than inhibition (Y.-Z. 
Huang et al., 2005).  
 
 Another approach of newer rTMS is termed paired associative stimulation (PAS). 
PAS was built using principles employed by associative LTP or the Hebbian concept 
described in animal studies. The general idea of the aforementioned concept is that the 
temporal order of the presynaptic and postsynaptic spiking determines whether LTP and 
LTD is induced when a weak and strong input are stimulated together (Levy & Steward, 
1983). PAS also exhibits fascilitatory and inhibitory effects on the excitability of the motor 
cortex in humans, depending on the inter-stimulus interval (ISI) between electrical 
peripheral nerve stimulation and cortical stimulation. If the ISI is shorter than the afferent 
delay (time required for the peripheral afferent input to reach the brain), PAS decreases 
corticomotor excitability. In contrary, if ISI is longer than the afferent delay, PAS increases 
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cortical excitability (Wolters et al., 2003). Neurophysiologic studies additionally describe 
the role of NMDA and GABAB receptors that cause the effects of PAS. It has also been 
proven that dopamine could also be responsible for inducing PAS after-effects 
(Hoogendam, Ramakers, & Di Lazzaro, 2010). For a clearer description, the types and 
properties of different patterns of rTMS are summarized in Figure 2.4.  
 
  
Figure 2.4: Simple repetitive TMS (rTMS) protocols consist of similar stimuli spaced by an 
identical inter-stimulus interval (ISI). The effects of simple rTMS depend on stimulation 
frequency: low frequency (< 1 Hz) rTMS depresses cortical excitability, whereas high 
frequency (> 5 Hz) increases cortical excitability. Theta burst stimulation (TBS) protocol 
